Skip to content

Public FDA record

Z-0632-05: DiaSorin Anti-Cardiolipin IgA ELISA kit for the detection in human serum or plasma of antoantibodies spec

Recall record Z-0632-05 for Diasorin Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0632-05
Company in FDA record
Diasorin Inc.
FDA classification date
Mar 18, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

DiaSorin Anti-Cardiolipin IgA kit's positive control is out of acceptable limits.

Source facts

Action
Customers were notified via a letter which described the product and the problem. Recommended to destroy all affected kits and stated that the kits will be replaced.
Initiated
2004-01-23
Root cause
Other
Terminated
2006-07-22
Distribution
GA, NY & KS
Recall number
Z-0632-05
Recall status
Terminated
CDRH record ID
36807
FDA classified
2005-03-18
Recall event number
30919

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗